Prognosis of patients with sickle cell disease and COVID-19: a French experience

Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19

Résumé en anglais

France is the country with the highest prevalence of sickle cell disease in Europe, with more than 26?000 patients diagnosed with the condition in 2018. Most of these patients are of sub-Saharan African origin. Patients with sickle cell disease are thought to be at increased risk of COVID-19 complications. Aside from specific COVID-19-related morbidities, infections in patients with sickle cell disease can provoke painful vaso-occlusive crisis and life-threatening acute chest syndrome. Thus, COVID-19 could be devastating for regions such as Africa or India, where an estimated 8–12 million patients with sickle cell disease live, or in the USA and Brazil, with more than 100?000 patients in each country. Nevertheless, there are currently no data on the outcomes of patients with sickle cell disease and COVID-19. (…)